Edition:
United States

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

2.33USD
18 Aug 2017
Change (% chg)

$-0.03 (-1.27%)
Prev Close
$2.36
Open
$2.34
Day's High
$2.35
Day's Low
$2.31
Volume
190,166
Avg. Vol
351,280
52-wk High
$5.01
52-wk Low
$2.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 December 18 Aug 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.43 2.43 2.43 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 6 1.09 1.60 0.00 0.50
Quarter Ending Dec-17 6 1.05 1.70 0.00 0.50
Year Ending Dec-17 6 7.51 8.60 5.40 14.30
Year Ending Dec-18 7 14.95 52.50 0.10 30.47
Earnings (per share)
Quarter Ending Sep-17 6 -0.27 -0.23 -0.31 -0.30
Quarter Ending Dec-17 6 -0.28 -0.22 -0.33 -0.29
Year Ending Dec-17 6 -1.09 -0.97 -1.23 -1.24
Year Ending Dec-18 7 -1.00 -0.78 -1.24 -1.26

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 1.05 3.83 2.78 264.98
Quarter Ending Mar-17 0.92 1.53 0.61 66.20
Quarter Ending Dec-16 1.08 1.87 0.80 74.00
Quarter Ending Sep-16 0.87 2.22 1.35 155.85
Quarter Ending Jun-16 0.85 1.39 0.54 63.41

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 1.09 1.09 0.90 0.90 0.50
Quarter Ending Dec-17 1.05 1.06 0.99 0.99 0.50
Year Ending Dec-17 7.51 7.06 4.26 4.26 14.30
Year Ending Dec-18 14.95 14.95 14.41 14.41 30.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 3 2
Quarter Ending Dec-17 0 0 2 3
Year Ending Dec-17 0 0 6 0
Year Ending Dec-18 0 0 2 0
Earnings